Merit Medical Systems (MMSI) EV to EBITDA (2010 - 2026)

Merit Medical Systems has disclosed EV to EBITDA across 17 years of filings, most recently posting 61.12 for Q2 2026.

• In Q2 2026, EV to EBITDA fell 44.84% year-over-year to 61.12; the TTM figure through Jun 2026 stood at 18.33 (down 42.91% YoY), while the FY2025 annual figure was 25.94, down 23.88% from the prior year.
• EV to EBITDA came in at 61.12 for Q2 2026 at Merit Medical Systems, down from 82.07 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 243.87 in Q1 2022 to a low of 61.12 in Q2 2026.
• Average EV to EBITDA over 5 years is 127.86, with a median of 121.5 recorded in 2022.
• Year-over-year, EV to EBITDA tumbled 67.64% in 2022 and soared 34.08% in 2025.
• Over 5 years, EV to EBITDA stood at 131.13 in 2022, then dropped by 13.61% to 113.29 in 2023, then gained by 28.07% to 145.09 in 2024, then plunged by 39.07% to 88.41 in 2025, then plunged by 30.87% to 61.12 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 61.12 in Q2 2026, 82.07 in Q1 2026, and 88.41 in Q4 2025.